The decision to issue a government-use licence to make a generic drug available is a breakthrough in the fight to cure 500,000 Hepatitis C patients in Malaysia.
A GOVERNMENT decision to make a generic Hepatitis C medicine available is expected to drastically bring down the treatment costs and potentially cure hundreds of thousands of Malaysian patients in the years ahead.
